Identification of acquired somatic mutations in the chromatin remodelling factor ATRX in the alpha thalassemia myelodysplasia syndrome (ATMDS).

Identification of acquired somatic mutations in the chromatin remodelling factor ATRX in the alpha thalassemia myelodysplasia syndrome (ATMDS).

Bibliografski detalji
Glavni autori:	Gibbons, R, Pellagatti, A, Garrick, D, Wood, W, Malik, N, Ayyub, H, Langford, C, Boultwood, J, Wainscoat, J, Higgs, D
Format:	Conference item
Izdano:	2003

Slični predmeti

Identification of acquired somatic mutations in the gene encoding chromatin-remodeling factor ATRX in the alpha-thalassemia myelodysplasia syndrome (ATMDS).
od: Gibbons, R, i dr.
Izdano: (2003)

Identification of acquired somatic mutations in the chromatin remodelling factor ATRX in the a thalassaemia myelodysplasia syndrome (ATMDS)
od: Gibbons, R, i dr.
Izdano: (2003)

Two novel somatic mutations of the ATRX gene in female patients with acquired alpha thalassemia of myelodysplastic syndrome (ATMDS).
od: Haas, P, i dr.
Izdano: (2006)

Acquired somatic ATRX mutations in myelodysplastic syndrome associated with alpha thalassemia (ATMDS) convey a more severe hematologic phenotype than germline ATRX mutations.
od: Steensma, D, i dr.
Izdano: (2004)

A novel splicing mutation in the gene encoding the chromatin-associated factor ATRX associated with acquired hemoglobin H disease in myelodysplastic syndrome (ATMDS)
od: Steensma, D, i dr.
Izdano: (2004)

Acquired alpha-thalassaernia in association with myelodysplastic syndrome (ATMDS): Two further private ATRX mutations
od: Fisher, C, i dr.
Izdano: (2007)

The chromatin remodeller ATRX: A repeat offender in human disease
od: Clynes, D, i dr.
Izdano: (2013)

The chromatin remodeller ATRX: a repeat offender in human disease.
od: Clynes, D, i dr.
Izdano: (2013)

The chromatin-remodeling protein ATRX is critical for neuronal survival during corticogenesis.
od: Bérubé, N, i dr.
Izdano: (2005)

DHPLC analysis of the ATRX gene in myelodysplastic syndrome (MDS) associated with acquired alpha thalassemia (AT-MDS): Novel mutation detection despite somatic mosaicism.
od: Steensma, D, i dr.
Izdano: (2003)

The chromatin remodelling factor ATRX suppresses R-loops in transcribed telomeric repeats
od: Nguyen, D, i dr.
Izdano: (2017)

Recognition of the nucleosome by the chromatin remodeler atrx
od: Feng, Xiaoyu
Izdano: (2017)

XNP/ATRX at sites of nucleosome replacement.
od: Garrick, D, i dr.
Izdano: (2009)

The role of chromatin remodeller ATRX in gene expression
od: Shen, Y
Izdano: (2022)

The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies.
od: Xue, Y, i dr.
Izdano: (2003)

Role of the chromatin remodeler ATRX in the regulation of gene expression
od: Truch, J
Izdano: (2018)

The role of X-inactivation in the gender bias of patients with acquired alpha-thalassaemia and myelodysplastic syndrome (ATMDS).
od: Haas, P, i dr.
Izdano: (2009)

Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation.
od: Gibbons, R, i dr.
Izdano: (2000)

ATRX: taming tandem repeats.
od: Gibbons, R, i dr.
Izdano: (2010)

Structural consequences of disease-causing mutations in the ATRX-DNMT3-DNMT3L (ADD) domain of the chromatin-associated protein ATRX.
od: Argentaro, A, i dr.
Izdano: (2007)

High-resolution genomic profiling of myelodysplasia (MDS) by microarray comparative genomic hybridisation (CGH)
od: Esoof, N, i dr.
Izdano: (2005)

Disruption of ATRX in mouse by conditional knockout.
od: Gibbons, R, i dr.
Izdano: (2002)

Mutations in the human ATRX gene, encoding a putative transcription regulator, cause diverse changes in the pattern of DNA methylation.
od: Garrick, D, i dr.
Izdano: (2000)

The chromatin remodelling factor dATRX is involved in heterochromatin formation.
od: Andrew R Bassett, i dr.
Izdano: (2008-05-01)

Mutations in the chromatin-associated protein ATRX.
od: Gibbons, R, i dr.
Izdano: (2008)

The chromatin remodeller ATRX facilitates diverse nuclear processes, in a stochastic manner, in both heterochromatin and euchromatin
od: Truch, J, i dr.
Izdano: (2022)

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.
od: Papaemmanuil, E, i dr.
Izdano: (2011)

A novel mutation in the last exon of ATRX in a patient with alpha-thalassemia myelodysplastic syndrome.
od: Costa, D, i dr.
Izdano: (2006)

5-Azacytidine treatment of the patient with ATMDS (vol 76, pg 432, 2006)
od: Costa, D, i dr.
Izdano: (2006)

The chromatin remodeller ATRX facilitates diverse nuclear processes, in a stochastic manner, in both heterochromatin and euchromatin
od: Julia Truch, i dr.
Izdano: (2022-06-01)

How does the chromatin remodeler ATRX identify its targets in the genome?
od: Nguyen, DTT
Izdano: (2014)

Glutathione S-transferase gene deletions in myelodysplasia.
od: Atoyebi, W, i dr.
Izdano: (1997)

ATRX dysfunction induces replication defects in primary mouse cells
od: Clynes, D, i dr.
Izdano: (2014)

Identification of mutations in ATRX by RNase mismatch cleavage.
od: Gibbons, R, i dr.
Izdano: (1997)

High-resolution genomic profiling of myelodysplasia (MDS) by microarray comparative genomic hybridization (CGH).
od: Esoof, N, i dr.
Izdano: (2006)

Chromosomal deletions in myelodysplasia.
od: Boultwood, J, i dr.
Izdano: (1995)

ATRX targets variable number tandem repeats and thereby influences allele-specific expression
od: Lower, K, i dr.
Izdano: (2010)

Loss of Atrx affects trophoblast development and the pattern of X-inactivation in extraembryonic tissues.
od: Garrick, D, i dr.
Izdano: (2006)

Loss of Atrx affects trophoblast development and the pattern of X-inactivation in extraembryonic tissues.
od: Garrick, D, i dr.
Izdano: (2006)

Acquired spherocytosis in the setting of myelodysplasia
od: Linda Katharina Karlsson, i dr.
Izdano: (2022-01-01)